Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives

Hypertension

Volumn 33, Issue 4, 1999, Pages 927-932

  Glenn, Cheryl L ^a   Wang, William Y S ^a   Morris, Brian J ^a  

^a NONE

Author keywords

Genetics, biochemical; Hypertension, essential; Linkage (genetics); Nitric oxide synthase; Polymerase chain reaction; Survival; Whites

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

EID: 0032916426     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.4.927     Document Type: Article

References (53)

1. Julier C, Delepine M, Keavney B, Tenvilliger J, Davis S, Weeks DE, Bui T, Jeunemaitre X, Velho G, Froguel P, Ratcliffe P, Corvol P, Soubrier F, Lathrop GM. Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet. 1997;6:2077-2086.
2. Rutherford S, Morris BJ, Griffiths LR. In search of hypertension gene loci: a genome-wide scan using affected siblings. Annu Sci Mtg Hum Genet Soc Aust. 1997;July:15.
3. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem. 1994;269:6765-6772.
4. Xu W, Charles IG, Liu L, Koni PA, Moncada S, Emson P. Molecular genetic analysis of the duplication of human inducible nitric oxide synthase (NOS2) sequences. Biochem Biophys Res Commun. 1995;212: 466-472.
5. Mayer B, Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci. 1997;22:477-481.
6. Mattson DL, Maeda CY, Bachman TD, Cowley AW. Inducible nitric oxide synthase and blood pressure. Hypertension. 1998;31:15-20.
7. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. Reduced plasma concentrations of nitric oxide in individuals with essential hypertension. Hypertension. 1997;30:405-408.
8. Devlin AM, Brosnan J, Graham D, Morion JJ, McPhaden AR, McIntyre M, Hamilton CA, Reid JL, Dominiczak AF. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol. 1998;274:H52-H59.
9. Singh A, Sventek P, Lariviere R, Thibault G, Schiffrin EL. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats. Am J Hypertens. 1996;9: 867-877.
10. Chou TC, Yen MH, Li CY, Ding YA. Alterations in nitric oxide synthase expression with aging and hypertension in rats. Hypertension. 1998;31: 643-648.
11. Lippoldt A, Gross V, Schneider K, Hansson A, Nadaud S, Schneider W, Bader M, Yagil C, Yagil Y, Luft FC. Nitric oxide synthase and reninangiotensin system gene expression in salt-sensitive and salt-resistant Sabra rats. Hypertension. 1997;30(part 1):409-415.
12. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
13. Chen PY, Gladish RD, Sanders PW. Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-sensitive rats. Hypertension. 1998; 31:918-924.
14. Hilbert P, Lindpainter K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyen B, Julier C, Takahashi S, Vincent M, Ganten D, Georges M, Lathrop GM. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature. 1991;353:521-529.
15. Jacob HJ, Lindpainter K, Lincoln SE, Kusumi K, Bunker RK, Mao Y-P, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67:213-224.
16. Dubay C, Vincent M, Samani NJ, Hilbert P, Kaiser MA, Beressi JP, Kotelevtsev Y, Beckmann JS, Soubrier F, Sassard J, Lathrop GM. Genetic determinants of diastolic and pulse pressure map to different loci in Lyon hypertensive rats. Nat Genet. 1993;3:354-357.
17. Pravenec M, Gauguier D, Schott JJ, Buard J, Kren V, Bila V, Szpirer C, Szpirer J, Wang JM, Huang H, St Lezin E, Spence MA, Flodman P, Printz M, Lathrop GM, Vergnaud G, Kurtz T. Mapping of quantitative trait loci for blood pressure and cardiac mass in the rat by genome scanning of recombinant inbred strains. J Clin Invest. 1995;96:1973-1978.
18. Schork NJ, Kreiger JE, Trolliet MR, Franchini KG, Koike G, Kreiger EM, Lander ES, Dzau VJ, Jacob HJ. A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res. 1995;5:164-172.
19. Nunokawa Y, Ishida N, Tanaka S. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Commun. 1994;200:802-807.
20. Bellamy R, Hill AVS. A bi-allelic tetranucleotide repeat in the promoter of the human inducible nitric oxide synthase gene. Clin Genet. 1997;52: 192-193.
21. Xu W, Liu L, Emson PC, Harrington CR, Charles IG. Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene. 1997;204: 165-170.
22. Michel D, Chatelain G, Herault Y, Brun G. The long repetitive polypurine/polypyrimidine sequence (TTCCC)48 forms DNA triplex with PU-PU-PY base triplets in vivo. Nucleic Acids Res. 1992;20:439-443.
23. Nickol JM, Felsenfeld G. DNA conformation at the 5′ end of the chicken adult β-globin gene. Cell. 1983;35:467-477.
24. Takeuchi K, Alexander RW, Nakamura Y, Tsujino T, Murphy TJ. Molecular structure and transcriptional function of the rat vascular AT(1a) angiotensin receptor gene. Circ Res. 1993;73:612-621.
25. Bennet ST, Todd JA. Human type I diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet. 1996;30:343-370.
26. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-1089.
27. Morris BJ, Jeyasingam CL, Zhang W, Curtain RP, Griffiths LR. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects. Hypertension. 1997;30:1640-1641.
28. Zee RYL, Ying L-H, Griffiths LR, Morris BJ. Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension. J Hypertens. 1991;9:825-830.
29. Morris BJ, Zee RYL, Ying L-H, Griffiths LR. Independent, marked associations of alleles of the insulin receptor and dipeptidyl carboxypeptidase-1 genes with essential hypertension. Clin Sci. 1993;85: 189-195.
30. Schrader AP, Zee RYL, Morris BJ. Association analyses of NsiI RFLP of human insulin receptor gene in hypertensives. Clin Genet. 1996;49: 74-78.
31. Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential hypertension. Nat Genet. 1996;12:122.Letter.
32. Hodge SE. The information contained in multiple sibling pairs. Genet Epidemiol. 1984;1:109-122.
33. Miller SA, Dykes KK, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215.
34. Davis S, Weeks DE. Comparison of nonparametric statistics for detection of linkage in nuclear families: single-marker evaluation. Am J Hum Genet. 1997;61:1431-1444.
35. Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet. 1988;42:113-124.
36. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. In: Kelsey JL, Marmot MG, Stolley PD, Vessey MP, eds. Monographs in Epidemiology and Biostalistics. Vol 19. New York, NY: Oxford University Press; 1993.
37. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037-2048.
38. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, Stults BM, Barlow GK, Schumacher MC, Lifton RP, Lalouel JM. Are there interactions and relations between environmental factors predisposing to high blood pressure? Hypertension. 1991;18(suppl I):I-29-I-37.
39. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11: 241-247.
40. Weeks DE, Lathrop M. Polygenic disease: methods for mapping complex disease traits. Trends Genet. 1995;11:513-519.
41. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
42. Takahashi Y, Nakayama T, Soma M, Uwabo J, Izumi Y, Kanmatsuse K. Association analysis of TG repeat polymorphism of the neuronal nitric oxide synthase gene with essential hypertension. Clin Genet. 1997;52: 83-85.
43. Bonnardeaux A, Nadaud S, Charru A, Jeunemeitre X, Corvol P, Soubrier F. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Hypertension. 1995;91:96-102.
44. Friend LR, Morris BJ, Gaffney PT, Griffiths LR. Examination of the role of nitric oxide synthase and renal kallikrein as candidate genes for essential hypertension. Clin Exp Pharmacol Physiol. 1996;23:564-566.
45. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M. Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension. Clin Genet. 1997;51: 26-30.
46. Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, Benetos A. nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens. 1997;16:31-35.
47. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 1997;100:2417-2423.
48. Shimabukuro M, Ohneda M, Lee Y, Unger RH. Role of nitric oxide in obesity-induced β cell disease. J Clin Invest. 1997;100:290-295.
49. Buttery LDK, Springall DR, Chester AH, Evans TJ, Standfield N, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
50. Ravalli S, Albala A, Ming M, Szabolcs M, Barbone A, Michler RE, Cannon PJ. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation. 1998;97:2338-2345.
51. Neaton JD, Kuller L, Stamler J, Wentworth DN. Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Laragh JH, Brenner BH, eds. Hypertension. Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press: 1995:127-144.
52. Rikitake Y, Hirata K, Kawashima S, Akita H, Yokoyama M. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells. Atherosclerosis. 1998;136:51-57.
53. Ohishi M, Fennessy PA, Ousting GJ, Mendelsohn FAO, Zhuo JL. Expression of the renin-angiotensin system and nitric oxide synthase during the development of human coronary atherosclerosis. Abstract Presented at: 21st Annual Scientific Meeting of the High Blood Pressure Research Council of Australia; December 10-12, 1998; Melbourne, Australia.